Detterbeck Frank C, Vansteenkiste Johan F, Morris David E, Dooms Christophe A, Khandani Amir H, Socinski Mark A
Division of Cardiothoracic Surgery, Medical School Wing C - Room 354, CB #7065, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7065, USA.
Chest. 2004 Nov;126(5):1656-66. doi: 10.1378/chest.126.5.1656.
Positron emission tomography (PET) imaging is an important tool to refine the diagnosis and staging approach in patients with a possible lung cancer. In addition, other applications of PET imaging are being explored. Data consistently show that the intensity of uptake on a PET scan correlates with the biological aggressiveness of a tumor. PET imaging for restaging after induction therapy does not appear to be accurate enough to guide management. The results of PET imaging late after completion of treatment are highly predictive of future survival, and changes in PET images after only one cycle of chemotherapy are predictive of how a patient will respond to that planned treatment. PET imaging may allow radiotherapy treatment fields to be planned with greater accuracy, although data on how this affects patient outcomes are not yet available. Further technologic improvements in PET scanners are likely to bring further benefits to the management of patients with lung cancer in the future.
正电子发射断层扫描(PET)成像对于优化疑似肺癌患者的诊断和分期方法而言是一项重要工具。此外,PET成像的其他应用也在探索之中。数据始终表明,PET扫描上的摄取强度与肿瘤的生物学侵袭性相关。诱导治疗后用于再分期的PET成像似乎不够准确,无法指导治疗管理。治疗完成后晚期的PET成像结果对未来生存具有高度预测性,仅一个化疗周期后PET图像的变化就能预测患者对该计划治疗的反应。PET成像可能使放射治疗野的规划更加精确,尽管关于这如何影响患者预后的数据尚未可得。未来,PET扫描仪的进一步技术改进可能会给肺癌患者的管理带来更多益处。